Corticosteroids changed dermatology in the mid-20th century. As someone who has worked directly with patients suffering from severe eczema, I can say the introduction of betamethasone valerate brought much-needed relief in ways that earlier treatments, like coal tar preparations, simply could not match. The birth of betamethasone derivatives stemmed from a rush to find potent yet safer anti-inflammatory agents. Researchers discovered that modifying the steroid backbone at precise positions boosted potency without ramping up risk, so the emergence of betamethasone valerate in the 1960s signaled a real shift. By offering a compound with greater anti-inflammatory strength than hydrocortisone but fewer systemic effects than its unmodified cousins, it quickly became a go-to option in dermatological practice. The regulatory agencies in both Europe and America approved it for topical use, reflecting both growing trust in steroid science and a rising burden of chronic skin conditions.
Betamethasone valerate goes by several names in global markets—Betnovate, Celestoderm-V, and more. It’s offered as cream, ointment, lotion, and even as a scalp application. From the pharmacy shelf to the consulting room, the tube of 0.1% cream stands out as a familiar sight. This is not just a product for the specialist toolkit; general practitioners prescribe it routinely for stubborn dermatitis, psoriasis, and allergic rashes. Most packaging includes information on short-term use and warnings against facial application or use in infants, based on years of side-effect surveillance. As clinicians, we’re cautious about pointing out these limits, but we cannot ignore the profound relief this medicine brings to patients enduring daily discomfort.
Betamethasone valerate appears as a white to creamy-white, odorless powder with a melting point around 183°C, which stands out compared to less potent topical agents. This compact, crystalline solid dissolves well in ethanol and acetone but not so much in water, which affects how you formulate topical treatments. Its chemical stability allows preparation in various bases, from emollient ointments to lightweight lotions. Dragging a dab of cream between your fingers, you can appreciate how formulation science shapes each product—the oily, thick ointment tends to linger, while the cream sinks in quickly and leaves minimal residue.
Labels on betamethasone valerate tubes outline the concentration—normally 0.1%—which reflects the sweet spot between strength and safety. State regulations dictate standards for particle size, purity (usually above 98%), and identification tests. The presence of preservatives like chlorocresol or parabens often triggers discussion in patient support groups, especially among those with allergy concerns. All external packaging features clear warnings about keeping the product away from eyes, using sparingly, and limiting duration, reflecting lessons learned over decades. From my time working in a compounding pharmacy, I’ve seen how small mislabeling errors can trigger confusion or lead to misuse, so accuracy and clarity in these details serve far more than regulatory checkboxes—they help real people manage their health safely.
Betamethasone valerate synthesis starts from betamethasone, a synthetic corticosteroid, using valeric acid to attach the valerate group at the 17-position of the steroid backbone. This step provides the chemical tweak that makes the compound more lipophilic, boosting its penetration into skin layers. The process runs through classic organic phases—acylation, purification, and crystallization—requiring careful monitoring of temperature and pH. Manufacturing batches depend on high-purity solvents, specialized glassware, and a sharp eye for changes in color or precipitate formation. Working behind the scenes in pharmaceutical research labs, I watched as the production team’s attention to detail played a crucial role; a few degrees’ fluctuation in temperature could affect yield and purity, so operational discipline remains key.
The valerate ester at the 17-position resists rapid hydrolysis, making betamethasone valerate longer acting in the skin. Modifying the molecule at other sites can adjust its solubility, potency, or metabolic profile; for instance, introducing a dipropionate group yields an even more potent skin formulation (betamethasone dipropionate). Hydrophilic derivatives have been developed for use in ophthalmic or nasal preparations. During stability testing, the compound’s resistance to light decomposition stands out. Researchers have used these data to build formulation guidelines that extend shelf life and limit degradation, which is an important consideration for patients living in warm climates or with inconsistent access to refrigeration.
Betamethasone valerate appears under several product names, including Betnovate, Celestoderm-V, Betaval, and others, reflecting regional licensing and branding preferences. Patients often hear only the brand name in casual conversation, but pharmacists know the synonyms—BMV, betnelan, and the like—from years of cross-referencing scripts. This patchwork of names can sow confusion for those seeking refills abroad or sifting through online advice. Tools like WHO’s INN (International Nonproprietary Names) list help clinicians keep terminology straight and ensure that care instructions remain clear no matter the brand on a box.
Safety measures around betamethasone valerate reflect decades of trial, error, and vigilance. Topical corticosteroids, especially moderate-potency agents like this one, carry the risk of causing dermal thinning, telangiectasia, and systemic absorption if misused. In clinic, you see the importance of face-to-face teaching: explaining fingertip unit dosing, demonstrating application to avoid eye contact, and emphasizing strict hand hygiene before and after use. Manufacturers follow Good Manufacturing Practices, with environmental monitoring, staff protective clothing, and exhaust systems to prevent cross-contamination. Annual audit cycles and random sample testing back up product safety claims. There remains a push for updated patient information leaflets, focused on real-world questions about safe use on sensitive skin, in children, or in the elderly.
Betamethasone valerate occupies a central spot in the dermatology tool kit. Patients with atopic dermatitis or plaque psoriasis rely on it during flare-ups to calm itching and reduce inflammation. In my experience, parents of young children with eczema learn quickly how this steroid can ease sleeplessness and restore damaged skin. Some clinicians expand its use to lichen planus or discoid lupus lesions, striking a balance between potent control and the risks of long-term steroid damage. In hospitals, we also use it on stubborn bug bites and allergic contact reactions. Many of us caution against use on the face, groin, or for prolonged periods, highlighting the fine line between short-term benefit and long-term harm.
Ongoing research looks at both novel delivery systems and minimizing steroid exposure. Scientists tinker with polymer-based gels, foam carriers, and lipid nanoparticles to push active ingredients deeper into the skin or reduce messy residue. Over the last decade, head-to-head trials with new non-steroid anti-inflammatory products (like calcineurin inhibitors or JAK inhibitors) reflect an intense drive to improve safety, especially for chronic users. Academic labs continue to map out metabolic pathways and identify drug-drug interactions. As someone who reviewed clinical trial protocols during postgraduate studies, I believe collaborations with real-world patients—building registries of response rates and tracking side effects—offer a crucial counterbalance to industry-led studies.
Animal toxicology and long-term surveillance in humans have set the outer limits for betamethasone valerate’s use. Systemic absorption risks rise with broken skin, occlusion, or high cumulative use, leading to concerns about adrenal suppression or Cushingoid effects. Case reports have described children with growth delays or facial skin atrophy when parents overused topical steroids, often without clear instructions from providers. Most poison control hotlines recommend washing the area and seeking prompt help if accidental swallowing or heavy exposure occurs. For environmental health, proper disposal and minimal water solubility mean these products pose little risk if thrown away with ordinary waste. In recent years, toxicologists have turned their attention to the risks of low-level steroid exposure in wildlife habitats, but so far, evidence remains limited.
The future for betamethasone valerate lies in smarter use, better formulations, and wider support for patient-led care. Interest has grown in combination products pairing steroids with antibiotics or antifungals, especially as resistance patterns shift and skin infections complicate chronic skin disease. On the regulatory side, pharmacovigilance now moves faster, with digital reporting and real-time alerts helping spot rare side effects or problems with off-label use. With skin microbiome research exploding, we may soon see paired treatments to offset steroid-driven bacterial imbalance or work synergistically with emollients and anti-inflammatory diets. More practitioners and patients want tailored care–pharmacogenomics, point-of-care diagnostics, telemedicine follow-up after prescription–to maximize healing and minimize risk. As experience shows, the smallest actions, like updating patient fact sheets or developing new educational apps, sometimes make the biggest difference for real people grappling with skin disease every day.
Betamethasone valerate sits behind pharmacy counters, usually in a small tube or bottle, ready to help folks struggling with skin problems. I grew up seeing it in our medicine cabinet because someone in my family always seemed to have eczema or a rash. It’s one of those creams that doctors hand out after a quick look at red, itchy patches. What really makes it important gets clear once you see how much suffering skin flare-ups can cause in daily life.
This medicine serves a big purpose for people dealing with conditions like eczema, psoriasis, or stubborn allergic reactions. It reels in swelling, redness, and itching by calming the immune system at the skin’s surface. Sometimes a person can’t stop scratching. Maybe the itch starts at the forearm, then spreads. Losing sleep over it feels miserable. Betamethasone valerate interrupts that cycle. In my experience, after just a couple of days of applying it, angry welts or scaly spots soften up, and the person starts to feel like themselves again.
Doctors, pharmacists, and dermatologists all mention one thing over and over: this medicine works well in the short run, but nobody should use it for weeks on end. Misusing it can thin the skin, cause stretch marks, or make skin infections worse. I've known parents who spot treat their kids’ eczema, counting the days and checking the skin every night. Once the rash fades, they stash the tube away. That kind of caution speaks to the power of these steroid creams.
Not every red rash calls for a steroid. Anyone who’s worried should ask their doctor—not just use an old prescription passed down from a friend. In my work talking to patients, I often remind folks that fungal infections need something different, and some people just react badly to steroids. Sensitive areas like the face, groin, and skin folds demand even more care. Lower strengths or alternatives sometimes make more sense.
There’s a temptation to go straight for a strong steroid cream the moment itching starts. That quick fix can backfire. Too much steroid can bring side effects: broken blood vessels, light patches, even acne. I’ve seen folks who tried to “knock out” a flare with daily steroid use for weeks, only to face new problems. Layering good skin habits—gentle soaps, moisturizers, short showers—can prevent symptoms from coming back and cut down how much steroid anyone needs.
Doctors keep looking for ways to help people manage these skin conditions for the long haul. Education plays a big role. People who learn about triggers, like fragrances or harsh detergents, can dodge some flares altogether. More clinics now offer nurse-led classes on taking care of chronic rashes without heavy reliance on prescription creams. I see promise in research into non-steroid treatments—some creams and ointments harness the body’s own systems.
Most of us never think twice about mild eczema or a rash from poison ivy until it lands us in real discomfort. For people with persistent problems, betamethasone valerate offers something close to normalcy. Quick relief means more restful sleep and fewer missed days at work or school. Used wisely and sparingly, it works as a powerful part of the toolkit for keeping skin healthy, letting people get back to living their lives—without constant interruption from irritation and pain.
Betamethasone valerate cream isn’t your everyday skin lotion. It’s a corticosteroid, which means it packs more punch than over-the-counter creams. In my time working alongside doctors and pharmacists, confusion often pops up about steroid creams. Some folks slather it on like sunscreen, hoping for speedier results. Others dab so little that their symptoms outlast their patience.
People with eczema, psoriasis, or stubborn rashes get this prescription more often than others. Once, a neighbor came to me stressing over an itchy patch on her elbow. She figured a big glob meant faster healing. The truth is, a thin layer works much better. Rubbing in too much or using it longer than prescribed can weaken the skin over time, which leads to more trouble later.
After washing hands with plain soap and water, I dry them well before touching the cream or the damaged skin. Clean, dry skin doesn't just help the cream spread better. It cuts down the risk of infection, especially if the skin is already raw or cracked.
Doctors usually mention applying the cream once or twice a day. That doesn’t mean using it every hour or putting on an extra layer after a shower. Most people see improvement with less product, used more carefully. I always remind friends: follow the “fingertip unit” approach. One fingertip’s worth covers an area around the size of two adult hands. Spreading a thin, even layer does more for healing than caking it on.
Steroids in skin creams work fast, which feels good. But over time, using too much can thin the skin or cause stretch marks—side effects nobody wants. In my own family, we’ve set alarms to remind us to stop using the cream after a week or two. This step helps avoid the temptation to keep reaching for the tube after symptoms ease off.
Doctors warn to skip broken, infected, or sensitive spots near the eyes, unless told otherwise. Once, I saw a teenager try the cream on broken acne—she ended up with worse redness. This taught us to listen to medical advice closely.
Medical studies confirm what most dermatologists repeat: corticosteroids treat flares best when used short-term. According to the National Eczema Association, stopping too suddenly after heavy use can even spark a rebound rash. To avoid that, some people taper down their use under supervision, gradually switching to plain moisturizer as the skin calms.
Never share this cream with someone else, even if their rash looks similar. Conditions may look the same on the surface, but different causes demand different treatment. Pharmacy teams point this out all the time, since sharing medicine—topical or not—brings hidden risks.
Correct use of betamethasone valerate cream speaks to trust between patient and prescriber. From my own experience supporting friends through chronic skin trouble, I know this trust changes everything. Education empowers people and helps prevent the setbacks caused by misuse. Better outcomes start with honest conversations about prescription details, regular check-ins with a professional, and treating medications like the strong tools they are.
Betamethasone valerate cream or ointment lives in many medicine cabinets and purses. Dermatologists often prescribe it for rashes, stubborn eczema, or psoriasis. As a medium-strength steroid, this stuff calms inflamed skin fast. Sometimes that’s what you need—a break from the itch and redness that just won’t quit.
Most folks expect relief. That usually happens. Honest truth, though, every medication works alongside a set of possibilities nobody wants. For this steroid, thinning of the skin ranks high. After weeks of use, skin may look shiny, even transparent. You might touch a patch and feel it’s lost some bounce. Bruising crops up more easily, too. A few patients I’ve seen show us paper-thin places after heavy use—especially where skin flexes or folds.
Sometimes, tiny blood vessels pop up just beneath the surface like feathery red webs. Not dangerous, but they change how skin looks. You won’t see these things the first or second week. Longer stretches, stronger steroids, or using it on delicate skin like the face or groin brings a real risk.
Most creams stick to the skin’s surface, but a few ingredients find their way deeper. Steroid creams can sneak through—particularly when used under dressings or diapers. That opens the door for more subtle side effects, including stretch marks, small bumps, or hair growth in places you least expect. Even though rare, kids and babies can absorb enough to tinker with growth or their hormone balance. For adults, changes in skin color sometimes stick around, lightening or darkening patches.
Allergies rarely pay a visit, but they can. Irony rears its head when the cure sparks more itching, redness, or swelling. Anyone who develops these symptoms should call their clinician. Fungal, viral, or bacterial skin infections—hidden at first—can thrive once inflammation quiets down. I’ve watched someone treat a rash, only for ringworm to bloom underneath.
Reading a list of possible reactions feels different than seeing someone experience them. Sometimes folks return, puzzled at sensitive, cracked skin where none existed before. Sometimes parents of young kids worry over slowed growth, especially after months of daily use. Numbers from dermatology studies show thinning happens in up to 20% of cases with heavy use. Infections show up a bit less often, but anyone prone to them should stay watchful.
Doctors and pharmacists flag these issues for a reason. It isn’t about fear—it’s about knowing what to watch for and when to pause. A lot of people (myself included) have reached for steroid cream after bug bites, stress rashes, or even mystery bumps. A little knowledge goes a long way, and honesty about risks lets us use these treatments wisely.
Sticking with the lowest dose for the shortest time matters. Coverage should stay thin; dabbing, not slathering, works best. Doctors steer folks away from using steroids on the face or genitals unless there’s no other option. Reading the label—every time—matters. Checking with your provider if you see thinning skin, odd streaks, or extra redness is smart, not overreacting.
Prescription steroids fill a real need. Used right, betamethasone valerate soothes what hurts and cools angry skin. Knowing what to look for, asking questions, and taking a break once inflammation settles prevents regret down the line. That practical approach saves a lot of trouble and keeps this useful medicine on your side.
Betamethasone valerate packs a punch as a topical steroid. It quickly quiets down angry rashes, stops itching, and calms stubborn redness from eczema, psoriasis, or allergic reactions. People often reach for it hoping for fast relief, but the story takes a twist when considering delicate areas like the face or sensitive skin in kids.
Skin on the face is thin and gets irritated easily. Kids’ skin is even more delicate, more prone to absorbing medicine. Applying strong steroids here opens the door to problems—thinning skin, visible blood vessels, stretch marks, even acne. I’ve seen anxious parents in clinic, shocked their child developed pale patches or spider veins near the nose after a few weeks of unsupervised use.
Medical literature backs this up. Studies link potent steroids used on the face to skin atrophy and steroid rosacea—sometimes tough to fix once they appear. The British National Formulary and the American Academy of Dermatology both say to limit strong steroid use on the face and in children, always stick to the lowest strength, and never use without a doctor guiding the plan.
Parents and adults stare at rashes and wonder, “Is this eczema, allergy, or maybe a fungal infection?” Mistakes easily happen. Betamethasone valerate wipes away symptoms, but it can hide infections or make them worse. I’ve watched ringworm flare up on a child’s cheek because the family thought it was regular eczema and kept slathering on the cream.
Doctors often see only the aftermath—thin skin, infections hiding under fading redness, sometimes months of slow healing. Skin specialists get called in to pick up the pieces.
Pausing before applying any steroid to the face or a child’s rash often saves trouble. If a rash stubbornly clings on, spreads, or bleeds, it calls for a doctor’s eyes. Trained eyes spot infections, differentiate eczema from psoriasis, and fine-tune treatment.
Dermatologists often choose milder hydrocortisone for the face and short durations for children. They might recommend skipping steroids altogether if a diagnosis is unclear or a yeast infection lurks underneath. Moisturizers, gentle cleansers, basic skin care—these get as much play as medicated creams, especially for children. Sometimes, just using a fragrance-free moisturizer and cold compresses works wonders for itchy cheeks.
Always check with a physician before putting strong steroids like betamethasone valerate on a child or face. Follow their instructions to the letter and use only the amount prescribed. Keep cream off thin-skinned areas like eyelids, lips, or groin unless specifically told it's safe. If a rash gets worse or doesn't improve within a week, schedule a follow-up.
Thousands trust topical steroids to clear up skin, but using them in the wrong spot or on the wrong age group can make simple problems complicated. Healthy skin, especially for kids and faces, deserves a careful, evidence-based approach—one that puts safety first but never loses sight of comfort or confidence.
Plenty of people deal with stubborn rashes, eczema, or psoriasis at some point. Looking for relief, many find Betamethasone Valerate among the top recommendations. It’s known as a potent topical steroid that cuts inflammation, tames itching, and helps skin return to normal. Shopping for it, you might ask yourself if the local pharmacy stocks it over the counter. The short answer: you’re going to need a prescription in the United States, the UK, Canada, and most places with stringent medication rules. Pharmacies might advertise ointments “for eczema,” but strong steroids like this don’t sit on the shelf for self-selection.
I remember reaching for a rash cream during a bad poison ivy stint in college, thinking stronger would mean better. Luckily, the pharmacist explained you can’t just pick up real corticosteroids like Betamethasone Valerate without a doctor’s sign-off. The reason makes sense. In expert hands, these creams settle stubborn irritation. Used on a whim, though, they can thin the skin, trigger infections, or mess up diagnoses if someone keeps hiding chronic problems under steroids without medical advice.
Doctors prescribe precise strengths and instructions depending on where you use the cream—thin skin like the face or folds needs a gentler touch. Children’s skin absorbs steroids faster, raising the risk of side effects. Self-medicating with high-powered creams because an internet forum recommended it doesn't do your skin any favors. The FDA and agencies across the globe keep these creams behind the counter to protect people from trouble caused by overuse, misdiagnosis, or dangerous mixing with other medicines.
Some people look for loopholes and order Betamethasone Valerate from overseas sources online. It feels like a shortcut, skipping the waiting room, but risks pile up quickly. You never quite know what’s in that tube or if it’s made safely. Studies keep finding counterfeit medicine and heavy metals in creams sold outside regulated channels. Skin doctors have seen infections and conditions made worse by using “imported” creams. Relying on unverified online sellers for medicine can throw a wrench into health plans and compromise recovery.
If you’re battling a rash that won’t quit, don’t write off the medical system as just another barrier. Many clinics offer telehealth visits these days, so getting advice and a script for a safe, effective steroid cream doesn’t always mean spending hours in a waiting room. Sometimes, a milder over-the-counter hydrocortisone cream will do the trick. Pharmacists are trained to help sort out mild cases from the ones needing a doctor’s look.
At the end of the day, smart medicine means respecting these boundaries. Betamethasone Valerate should stay a prescription treatment, not just to follow rules but to protect people from the long-term cost of short-term fixes. Caring for your skin usually means caring for your whole health.
| Names | |
| Preferred IUPAC name | (11β,16β)-9-fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl valerate |
| Other names |
Betnovate
Celestone Valerate Beta-Val Luxiq Valisone Betnovate-N Betaderm |
| Pronunciation | /ˌbiːtəˈmiːθəsoʊn ˈvæləˌreɪt/ |
| Preferred IUPAC name | (11β,16β)-9-Fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl valerate |
| Other names |
Betnovate
Betaderm Celestone Valerate Beta Val Luxiq |
| Pronunciation | /ˌbiː.təˌmiː.θəˈsoʊn ˈvæl.əˌreɪt/ |
| Identifiers | |
| CAS Number | 2152-44-5 |
| Beilstein Reference | 113128 |
| ChEBI | CHEBI:30681 |
| ChEMBL | CHEMBL1204 |
| ChemSpider | 215596 |
| DrugBank | DB00443 |
| ECHA InfoCard | 100.043.388 |
| EC Number | 201-566-0 |
| Gmelin Reference | 56035 |
| KEGG | C07238 |
| MeSH | D017060 |
| PubChem CID | 16752 |
| RTECS number | WQ2455000 |
| UNII | 76R8Y52I2Y |
| UN number | UN2811 |
| CompTox Dashboard (EPA) | DTXSID2012174 |
| CAS Number | 2152-44-5 |
| Beilstein Reference | 1532028 |
| ChEBI | CHEBI:3078 |
| ChEMBL | CHEMBL1204527 |
| ChemSpider | 21559673 |
| DrugBank | DB00443 |
| ECHA InfoCard | ECHA InfoCard: 1000408-629 |
| EC Number | 3.2.1.20 |
| Gmelin Reference | 88217 |
| KEGG | C16113 |
| MeSH | D001749 |
| PubChem CID | 22257 |
| RTECS number | CQ8525000 |
| UNII | YA6V2XW8PS |
| UN number | UN number not assigned |
| CompTox Dashboard (EPA) | DB00810 |
| Properties | |
| Chemical formula | C27H37FO6 |
| Molar mass | 476.587 g/mol |
| Appearance | White to almost white, odorless, crystalline powder |
| Odor | Odorless |
| Density | 1.03 g/cm3 |
| Solubility in water | Practically insoluble in water |
| log P | 2.56 |
| Acidity (pKa) | 12.59 |
| Basicity (pKb) | 12.72 |
| Magnetic susceptibility (χ) | -726.0e-6 cm^3/mol |
| Refractive index (nD) | 1.512 |
| Dipole moment | 1.96 D |
| Chemical formula | C27H37FO6 |
| Molar mass | 476.582 g/mol |
| Appearance | white to almost white cream |
| Odor | Odorless |
| Density | 0.991 g/cm3 |
| Solubility in water | Practically insoluble in water |
| log P | 2.56 |
| Acidity (pKa) | 12.59 |
| Basicity (pKb) | 5.71 |
| Magnetic susceptibility (χ) | -7.3e-7 |
| Refractive index (nD) | 1.510 |
| Viscosity | Viscous liquid |
| Dipole moment | 2.06 D |
| Pharmacology | |
| ATC code | D07AC01 |
| ATC code | D07AC01 |
| Hazards | |
| Main hazards | May cause eye irritation, skin irritation, allergic reactions, and suppression of the hypothalamic-pituitary-adrenal (HPA) axis with prolonged use. |
| GHS labelling | GHS labelling: Not classified as hazardous according to GHS. |
| Pictograms | Pictograms": "GHS07 |
| Signal word | Warning |
| Precautionary statements | Keep out of reach of children. For external use only. Avoid contact with eyes. Do not use on broken or infected skin unless directed by a doctor. Discontinue use if irritation or sensitivity occurs. Use only as directed by your physician. |
| Flash point | 215.6°C |
| Lethal dose or concentration | LD50 (Rat, oral): >3 g/kg |
| LD50 (median dose) | LD50 (median dose) of Betamethasone Valerate is 316 mg/kg (rat, oral) |
| NIOSH | MF9275Y9D7 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 30–60 g weekly |
| Main hazards | May cause eye irritation; may cause skin irritation; may be harmful if swallowed; avoid inhalation of dust or vapors. |
| GHS labelling | GHS07: Exclamation mark |
| Pictograms | eye irritation, skin irritation, health hazard |
| Signal word | Warning |
| Hazard statements | Hazard statements: May cause damage to organs through prolonged or repeated exposure. |
| Precautionary statements | Keep out of reach of children. For external use only. Avoid contact with eyes. Do not use on broken or infected skin. If irritation develops, discontinue use and consult a physician. |
| NFPA 704 (fire diamond) | NFPA 704: 1-1-0 |
| Flash point | 207.2 °C |
| Lethal dose or concentration | LD50 (rat, oral): >3,000 mg/kg |
| LD50 (median dose) | LD50 (median dose) of Betamethasone Valerate is "3,100 mg/kg (rat, oral)". |
| NIOSH | NQ8222060 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 30 micrograms per square centimetre |
| IDLH (Immediate danger) | Not Established |
| Related compounds | |
| Related compounds |
Betamethasone
Betamethasone dipropionate Betamethasone sodium phosphate Betamethasone acetate Hydrocortisone valerate Clobetasol propionate Fluticasone propionate |
| Related compounds |
Betamethasone
Betamethasone dipropionate Betamethasone sodium phosphate Betamethasone acetate Clobetasol propionate Hydrocortisone valerate |
| Thermochemistry | |
| Std molar entropy (S⦵298) | Std molar entropy (S⦵298) of Betamethasone Valerate is 770.9 J·mol⁻¹·K⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | -8898 kJ/mol |
Providing high-quality chemical products and logistics solutions for global trade partners.
